Vaishali Humnabadkar

Author PubWeight™ 7.74^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Azaindoles: noncovalent DprE1 inhibitors from scaffold morphing efforts, kill Mycobacterium tuberculosis and are efficacious in vivo.	J Med Chem	2013	0.97
2	Novel N-linked aminopiperidine-based gyrase inhibitors with improved hERG and in vivo efficacy against Mycobacterium tuberculosis.	J Med Chem	2014	0.93
3	Aminopyrazinamides: novel and specific GyrB inhibitors that kill replicating and nonreplicating Mycobacterium tuberculosis.	ACS Chem Biol	2012	0.90
4	Discovery of pyrazolopyridones as a novel class of noncovalent DprE1 inhibitor with potent anti-mycobacterial activity.	J Med Chem	2014	0.89
5	Optimization of pyrrolamides as mycobacterial GyrB ATPase inhibitors: structure-activity relationship and in vivo efficacy in a mouse model of tuberculosis.	Antimicrob Agents Chemother	2013	0.87
6	4-aminoquinolone piperidine amides: noncovalent inhibitors of DprE1 with long residence time and potent antimycobacterial activity.	J Med Chem	2014	0.82
7	Lead optimization of 1,4-azaindoles as antimycobacterial agents.	J Med Chem	2014	0.82
8	Thiazolopyridine ureas as novel antitubercular agents acting through inhibition of DNA Gyrase B.	J Med Chem	2013	0.78
9	Pyrazolopyrimidines establish MurC as a vulnerable target in Pseudomonas aeruginosa and Escherichia coli.	ACS Chem Biol	2014	0.77